Oak Ridge Investments LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,071 shares of the healthcare conglomerate’s stock after buying an additional 2,125 shares during the period. UnitedHealth Group comprises approximately 1.9% of Oak Ridge Investments LLC’s holdings, making the stock its 11th largest holding. Oak Ridge Investments LLC’s holdings in UnitedHealth Group were worth $23,082,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Citizens National Bank Trust Department grew its stake in UnitedHealth Group by 1.0% in the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after purchasing an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its stake in UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $515,000. Full Sail Capital LLC grew its stake in UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after purchasing an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth about $39,413,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Up 4.0%
Shares of UNH opened at $271.92 on Thursday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock has a market capitalization of $246.27 billion, a price-to-earnings ratio of 11.78, a PEG ratio of 1.69 and a beta of 0.43. The stock has a 50 day moving average price of $289.37 and a 200 day moving average price of $401.34.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.3%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.
Insider Activity
In other news, CEO Stephen J. Hemsley bought 86,700 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.28% of the company’s stock.
Wall Street Analysts Forecast Growth
UNH has been the subject of several recent analyst reports. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Morgan Stanley lowered their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Piper Sandler decreased their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Finally, Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $366.52.
Read Our Latest Analysis on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Tesla’s Pennant Just Snapped: Here’s What It Means for the Stock
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Companies That Will Profit From Trump’s Semiconductor Tariffs
- Stock Splits, Do They Really Impact Investors?
- 3 Earnings Reports Give a Snapshot of Consumer Sentiment
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.